ERBB2 and breast cancer: Our results propose that among the many biological effects of Her-2/neu overexpression the activation of the Akt survival pathway via the FAK Tyr-861–Src Tyr-215 pathway might contribute to the more aggressive behavior of Her-2/neu-overexpressing breast cancers.